<DOC>
	<DOCNO>NCT02209545</DOCNO>
	<brief_summary>The aim research work assess impact single preoperative dose buccal misoprostol reduce blood loss abdominal fibroid surgery .</brief_summary>
	<brief_title>Misoprostol Reduction Blood Loss During Fibroid Surgery</brief_title>
	<detailed_description>This trial woman undergo fibroid surgery university-affiliated tertiary care center . Eligible participant randomize receive preoperative 400ucg buccal ( tongue ) misoprostol placebo basis total fibroid volume , location , parity . Intra-operative blood loss compare group .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Patients present abdominal myomectomy document uterine fibroid pelvic imaging ( pelvic ultrasound MRI ) within last 12 month Age ≥ 18 year ≤ 50 year Preoperative hemoglobin &gt; 8 g/dl Willing buccal administration misoprostol placebo least one hour preprocedure . Ability understand willingness sign write informed consent . Admissible medical/surgical history Can previously treat DepoLupron , DepoProvera , Oral Contraceptive pill Intraoperative use vasopressin uterine tourniquet permissible Can prior Cesarean delivery Patients prior abdominal myomectomy Postmenopausal woman Patients known bleeding/clotting disorder Patients history gynecologic malignancy History allergic reaction attribute compound similar chemical biologic composition misoprostol Any case convert abdominal hysterectomy additional elective surgical procedure perform time abdominal myomectomy exclude data analysis Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>fibroid , leiomyomata , blood loss , misoprostol</keyword>
</DOC>